Contributor Page
Reed Smith
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 412 2883131
Fax: +1 412 2883063
Reed Smith Centre, 225 Fifth Avenue
Pittsburgh
PA 15222
United States
By Steven Boranian
Sometimes judges save what they really want to say for the end of their orders; and sometimes, even when one side clearly and justifiably prevails in a lawsuit ...
By Stephen J. McConnell
A product is not defective simply because someone was harmed by it. That seems a simple enough point.
By Cindy Schmitt Minniti, Mark S. Goldstein, Leora Grushka
A New York City Council member recently proposed an amendment to the New York City Human Rights Law (NYCHRL) ...
By Michelle Yeary
It's very hard to win a fraudulent joinder motion on the merits and thus keep a case in federal court. In fact, when we looked back at the topic on the blog ...
By Abraham Colman, Tuan V. Uong, Jason M. Ingber
The Ninth U.S. Circuit Court of Appeals majority opinion, reversed the grant of summary by the District Court that a loan owner ...
By Leigh Hansson, Alexander Brandt, Eli Rymland-Kelly, William Young, Gautam Lamba
On Monday, March 25, 2019, the U.S. Department of the Treasury's Office of Foreign Assets Control (OFAC) updated the advisory document it published in November 2018 on the risks for parties
By James Beck
We've already discussed many of the implications of Bristol-Myers Squibb Co. v. Superior Court, 137 S. Ct. 1773 (2017) ("BMS"), for personal jurisdiction in mass tort cases.
By Michelle Yeary
Making its presence felt as an early contender for a 2019 Top Ten DDL case, it's In re: Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation, 2019 WL 1284176
By Herbert Kozlov, Peter Malyshev, Le-el Sinai
The Commodity Futures Trading Commission ("CFTC") held a public meeting of the Technology Advisory Committee ("TAC") on March 27, 2019.
By James Segroves
The Supreme Court of the United States heard oral argument on March 27, 2019 concerning a case (Kisor v. Wilkie, No. 18-15) involving the Department of Veteran Affairs (VA).
By James Segroves
In litigation challenging the actions of any federal agency, the level of deference a court must show to the agency often dictates the outcome.
By James Beck
We've blogged before about the substantive (preemption) and procedural (removal) aspects of the Eliquis MDL
By Stephen J. McConnell
When the blog receives a case that is a bit off-center, involving odd facts or a different area of law, we grab it as our weekly writing assignment.
By Debra McCurdy
Reducing prescription drug prices is a major theme in the Trump Administration's fiscal year (FY) 2020 budget proposal, with policies intended to increase competition, encourage better negotiation,
By Elizabeth Carder-Thompson, Debra McCurdy
The Trump Administration's proposed fiscal year (FY) 2020 budget includes extensive health policy provisions – as evidenced by the 162-page Department of Health and Human Services (HHS)
Contributor's Topics
More...